Grace Therapeutics
Company Details
About: Acasti Pharma Inc. (ACST) is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. The Company's novel drug delivery technology platforms provide a versatile and flexible capability to develop and manufacture a wide range of pharmaceutical dosage forms, including oral, injectable, and topical, as well as various products to treat rare and orphan diseases. Acasti's lead product candidate is CaPre, an omega-3 phospholipid therapeutic for the treatment of severe hypertriglyceridemia, a condition that affects an estimated one third of the U.S. population. The Company is also developing a medical food, Onemia, for the treatment of patients with hypertriglyceridemia. Acasti Pharma is headquartered in Laval, Quebec, Canada.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Grace Therapeutics | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.